FDA Advisory Panel Recommends Nonopioid Lofexidine to Treat Opioid Withdrawal Symptoms, Despite Concerns : Topics in Pain Management

Journal Logo

Advanced Search
ARTICLE

FDA Advisory Panel Recommends Nonopioid Lofexidine to Treat Opioid Withdrawal Symptoms, Despite Concerns

Topics in Pain Management 33(11):p 8-9, June 2018. | DOI: 10.1097/01.TPM.0000534729.04193.7b
© 2018 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid